Evidence map›Paper›PMID 39113298›Full record

ReviewMini reviews in medicinal chemistry2025

The Development History, Structural Composition, and Functions of Influenza Viruses and the Progress of Influenza Virus Inhibitors in Clinics and Clinical Trials.

Jianping Yong, Shaoji Lu, Canzhong Lu, Ruiwen Huang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mini reviews in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Clinical characteristics and co-infection analysis of influenza a virus in pediatric respiratory infections: a study based on tNGS technology.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jianping YongFujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China.
Shaoji LuXiamen Tasman Bio-Tech Co., Ltd., Xiamen, Fujian, China.
Canzhong LuFujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China.
Ruiwen HuangXiamen Tasman Bio-Tech Co., Ltd., Xiamen, Fujian, China.

Funding

Cooperation Program of Xiamen Institute of Rare-earth Materials and Xiamen Tasman BIOTECH Co., Ltd 2022350204002401, 2022350204004248Science and Technology Planning Program of Xiamen 2022CXY0702, 2023CXY0701
6 · The paper itself

Abstract

Flu is an acute respiratory disease caused by influenza viruses. The influenza viruses are classified as

Indexed as

Antiviral AgentsEnzyme InhibitorsInfluenza, HumanOrthomyxoviridaeAnimalsClinical Trials as TopicDrug DevelopmentHumansNeuraminidaseAntiviral AgentsEnzyme InhibitorsNeuraminidaseanti-influenza drugs in clinicsinfluenza.influenza viral inhibitors in clinical trialsInfluenza virusesOrthomyxoviridae familysurface glycoproteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.